Madrigal Reports Third-Quarter 2026 Financial Results

Precision Biosciences Reports Third-Quarter 2026 Results Revenue was $0 versus $13K a year earlier. Net loss narrowed to $7.6M from $21.8M, including a $12.7M non-cash gain from changes in warrant fair value. Diluted EPS was $(0.28), com M impact | EQUITY | Nov 03, 2026, 01:19 PM UTC

Clarivate Reports Third-Quarter Revenue of $481.6 Million and Net Loss Third-quarter 2026 revenue fell 9.2% to $481.6 million from $530.3 million a year earlier. Net loss was $80.8 million, or $0.13 per diluted share, versus a $28.3 million net loss a M impact | EQUITY | Nov 03, 2026, 01:11 PM UTC

Faeth Therapeutics Reports Third-Quarter Net Loss of $20.4 Million Faeth reported a $20.4 million net loss for the third quarter of 2026, compared with a $4.6 million loss a year earlier. Basic and diluted loss per share narrowed to $0.79 from $3. M impact | EQUITY | Nov 03, 2026, 01:11 PM UTC

Dynatrace Reports Fiscal Q2 Revenue of $579.92 Million, EPS of $0.23 Revenue rose 17.4% year over year to $579.92 million. Net income increased 18.4% to $67.76 million, and diluted EPS rose 21.1% to $0.23. M impact | EQUITY | Nov 03, 2026, 01:11 PM UTC

Sysco Names Brandon Sewell Chief Financial Officer Sysco named Brandon Sewell its chief financial officer. L impact | EQUITY | Nov 03, 2026, 01:11 PM UTC

Chegg Sees Q4 Revenue of $38 Million to $40 Million M impact | EQUITY | Nov 03, 2026, 01:11 PM UTC

Madrigal Reports Third-Quarter 2026 Financial Results

Story updates

Related stories